BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 35085338)

  • 1. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.
    Leulseged TW; Abebe KG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Bayisa AB; Siyoum DF; Edo MG; Mesfin EG; Derejie MN; Shiferaw HK
    PLoS One; 2022; 17(1):e0262896. PubMed ID: 35085338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.
    Leulseged TW; Hassen IS; Maru EH; Zewsde WC; Chamiso NW; Bayisa AB; Abebe DS; Ayele BT; Yegle KT; Edo MG; Gurara EK; Damete DD; Tolera YA
    PLoS One; 2021; 16(11):e0259454. PubMed ID: 34752481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study.
    Leulseged TW; Alemahu DG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Abebe DS; Abdi FM; Minyelshewa EY; Gerbi TG; Hagos HT
    BMC Infect Dis; 2021 Aug; 21(1):759. PubMed ID: 34353283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of COVID-19 severity in Ethiopia: a multicentre case-control study.
    Tadie MB; Yimer YS; Taye G
    BMJ Open; 2024 May; 14(5):e083076. PubMed ID: 38803268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study.
    Leulseged TW; Maru EH; Hassen IS; Zewde WC; Chamiso NW; Abebe DS; Jagema TB; Banegyisa AB; Gezahegn MA; Tefera OS; Shiferaw WG; Admasu TT
    Pan Afr Med J; 2021; 38():351. PubMed ID: 34367430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022.
    Sane AH; Mekonnen MS; Tsegaw MG; Zewde WC; Mesfin EG; Beyene HA; Ashine TM; Tiruneh KG; Mengistie MA
    J Diabetes Res; 2022; 2022():9652940. PubMed ID: 36420090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological impact of COVID-19 outbreak among Jimma University Medical Centere visitors in Southwestern Ethiopia: a cross-sectional study.
    Yitayih Y; Lemu YK; Mekonen S; Mecha M; Ambelu A
    BMJ Open; 2021 Jan; 11(1):e043185. PubMed ID: 33408210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.
    Leulseged TW; Hassen IS; Ayele BT; Tsegay YG; Abebe DS; Edo MG; Maru EH; Zewde WC; Naylor LK; Semane DF; Dresse MT; Tezera BB
    PLoS One; 2021; 16(3):e0246087. PubMed ID: 33720944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of COVID-19 on poor treatment control among ambulatory Hypertensive and/or Diabetic patients in Northwest Ethiopia.
    Ayele TA; Shibru H; Mequanent Sisay M; Melese T; Fentie M; Azale T; Belachew T; Shitu K; Alamneh TS
    PLoS One; 2022; 17(5):e0266421. PubMed ID: 35588110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of patients infected with SARS-CoV-2 in North Wollo Zone, North-East Ethiopia.
    Geteneh A; Alemnew B; Tadesse S; Girma A
    Pan Afr Med J; 2021; 38():217. PubMed ID: 34046123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Socio-demographic Profile of the First 33 COVID-19 Cases Treated at Dedicated Treatment Center in Ethiopia.
    Teklu S; Sultan M; Azazh A; Worku A; Redae B; Walelegn M; Tefera M; Argaw R; Waganew W; Yifru S; Amogne W; Tssema N; Bekele A; Gebregziabher Y; Araya H; Birhanu A; Demoz G; Tadesse B; Seman Y; Abayneh A
    Ethiop J Health Sci; 2020 Sep; 30(5):645-652. PubMed ID: 33911824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hypertension and other factors associated with the severity of disease in COVID-19 pneumonia, Addis Ababa, Ethiopia: A case-control study.
    Ashamo AY; Bekele A; Petrose A; Gebreyes T; Etissa EK; Bekele A; Haisch D; Schluger NW; Yusuf H; Haile T; Deyessa N; Kebede D
    PLoS One; 2022; 17(8):e0273012. PubMed ID: 35969590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anxiety towards COVID-19 and its associated factors among healthcare workers in a Hospital of Ethiopia.
    Kibret S; Teshome D; Fenta E; Hunie M; Tamire T
    PLoS One; 2020; 15(12):e0243022. PubMed ID: 33290427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.
    Geng MJ; Wang LP; Ren X; Yu JX; Chang ZR; Zheng CJ; An ZJ; Li Y; Yang XK; Zhao HT; Li ZJ; He GX; Feng ZJ
    Infect Dis Poverty; 2021 Apr; 10(1):48. PubMed ID: 33845915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Poor Treatment Outcome among Hospitalized COVID-19 Patients in South Central, Ethiopia.
    Kaso AW; Hareru HE; Kaso T; Agero G
    Biomed Res Int; 2022; 2022():4551132. PubMed ID: 35252447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
    Elias TP; Gebreamlak TW; Gebremeskel TT; Adde BL; Abie AS; Elias BP; Argaw AM; Tenaw AA; Belay BM
    PLoS One; 2024; 19(5):e0298409. PubMed ID: 38728331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The applicability of basic preventive measures of the pandemic COVID-19 and associated factors among residents in Guraghe Zone.
    Dessu S; Tsehay T; Girum T; Timerga A; Solomon M; Tsegaye B; Geremew M; Migora B; Mesfin Y; Kemal A; Alebel F; Tolosa O; Tesfa S; Yasin F
    PLoS One; 2021; 16(8):e0256598. PubMed ID: 34432844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
    Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; Sciascia do Olival G; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
    Neurology; 2021 Nov; 97(19):e1870-e1885. PubMed ID: 34610987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden and risk profile of acute kidney injury in severe COVID-19 pneumonia admissions: a Finding from Jimma University medical center, Ethiopia.
    Umer EK; Abebe AT; Kebede YT; Bekele NT
    BMC Nephrol; 2024 Mar; 25(1):109. PubMed ID: 38504176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.